Lisinoplus 10+12,5 mg tabletter 덴마크 - 덴마크어 - Lægemiddelstyrelsen (Danish Medicines Agency)

lisinoplus 10+12,5 mg tabletter

stada arzneimittel ag - hydrochlorthiazid, lisinoprildihydrat - tabletter - 10+12,5 mg

Lisinoplus 20+12,5 mg tabletter 덴마크 - 덴마크어 - Lægemiddelstyrelsen (Danish Medicines Agency)

lisinoplus 20+12,5 mg tabletter

stada arzneimittel ag - hydrochlorthiazid, lisinoprildihydrat - tabletter - 20+12,5 mg

Ramipril/hydrochlorthiazid "ratiopharm" 5+25 mg tabletter 덴마크 - 덴마크어 - Lægemiddelstyrelsen (Danish Medicines Agency)

ramipril/hydrochlorthiazid "ratiopharm" 5+25 mg tabletter

ratiopharm gmbh - hydrochlorthiazid, ramipril - tabletter - 5+25 mg

Ramipril "ratiopharm" 10 mg tabletter 덴마크 - 덴마크어 - Lægemiddelstyrelsen (Danish Medicines Agency)

ramipril "ratiopharm" 10 mg tabletter

ratiopharm gmbh - ramipril - tabletter - 10 mg

Ramipril "ratiopharm" 2,5 mg tabletter 덴마크 - 덴마크어 - Lægemiddelstyrelsen (Danish Medicines Agency)

ramipril "ratiopharm" 2,5 mg tabletter

ratiopharm gmbh - ramipril - tabletter - 2,5 mg

Ramipril "ratiopharm" 5 mg tabletter 덴마크 - 덴마크어 - Lægemiddelstyrelsen (Danish Medicines Agency)

ramipril "ratiopharm" 5 mg tabletter

ratiopharm gmbh - ramipril - tabletter - 5 mg

Trandolapril "Aurobindo" 0,5 mg kapsler, hårde 덴마크 - 덴마크어 - Lægemiddelstyrelsen (Danish Medicines Agency)

trandolapril "aurobindo" 0,5 mg kapsler, hårde

aurobindo pharma (malta) limited - trandolapril - kapsler, hårde - 0,5 mg

Trandolapril "Aurobindo" 2 mg kapsler, hårde 덴마크 - 덴마크어 - Lægemiddelstyrelsen (Danish Medicines Agency)

trandolapril "aurobindo" 2 mg kapsler, hårde

aurobindo pharma (malta) limited - trandolapril - kapsler, hårde - 2 mg

Kantor Flydende middel 덴마크 - 덴마크어 - SEGES Landbrug & Fødevarer

kantor flydende middel

agroplanta gmbh & co. kg - additiv - flydende middel - 1000 g/l additiv

Zejula 유럽 연합 - 덴마크어 - EMA (European Medicines Agency)

zejula

glaxosmithkline (ireland) limited - niraparib (tosilate monohydrate) - fallopian tube neoplasms; peritoneal neoplasms; ovarian neoplasms - antineoplastiske midler - zejula is indicated: , as monotherapy for the maintenance treatment of adult patients with advanced epithelial (figo stages iii and iv) high-grade ovarian, fallopian tube or primary peritoneal cancer who are in response (complete or partial) following completion of first-line platinum-based chemotherapy. , as monotherapy for the maintenance treatment of adult patients with platinum sensitive relapsed high grade serous epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in response (complete or partial) to platinum based chemotherapy.